Caprock Group LLC Acquires 2,222 Shares of Genpact Limited (NYSE:G)

Caprock Group LLC raised its holdings in Genpact Limited (NYSE:GFree Report) by 22.9% during the fourth quarter, Holdings Channel reports. The institutional investor owned 11,938 shares of the business services provider’s stock after buying an additional 2,222 shares during the quarter. Caprock Group LLC’s holdings in Genpact were worth $513,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the business. JPMorgan Chase & Co. lifted its position in shares of Genpact by 192.8% during the third quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider’s stock valued at $122,701,000 after purchasing an additional 2,060,595 shares in the last quarter. Los Angeles Capital Management LLC bought a new position in shares of Genpact during the third quarter valued at about $19,779,000. Tandem Investment Advisors Inc. bought a new position in shares of Genpact during the third quarter valued at about $17,025,000. Geode Capital Management LLC lifted its position in shares of Genpact by 12.6% during the third quarter. Geode Capital Management LLC now owns 3,691,406 shares of the business services provider’s stock valued at $148,142,000 after purchasing an additional 413,646 shares in the last quarter. Finally, Franklin Resources Inc. lifted its position in shares of Genpact by 6.5% during the third quarter. Franklin Resources Inc. now owns 4,148,185 shares of the business services provider’s stock valued at $162,318,000 after purchasing an additional 252,674 shares in the last quarter. 96.03% of the stock is owned by institutional investors.

Insider Activity at Genpact

In other Genpact news, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction that occurred on Friday, December 13th. The shares were sold at an average price of $44.60, for a total transaction of $606,560.00. Following the completion of the sale, the chief executive officer now directly owns 267,404 shares in the company, valued at $11,926,218.40. The trade was a 4.84 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Piyush Mehta sold 12,000 shares of Genpact stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the sale, the senior vice president now owns 151,182 shares of the company’s stock, valued at approximately $6,475,125.06. The trade was a 7.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 35,058 shares of company stock valued at $1,558,675. Corporate insiders own 2.80% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the stock. Jefferies Financial Group upgraded shares of Genpact from a “hold” rating to a “buy” rating and raised their price objective for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. TD Cowen raised their price objective on shares of Genpact from $40.00 to $45.00 and gave the stock a “hold” rating in a report on Friday, November 8th. Robert W. Baird raised their price objective on shares of Genpact from $44.00 to $48.00 and gave the stock a “neutral” rating in a report on Friday, November 8th. Finally, Needham & Company LLC raised their price objective on shares of Genpact from $42.00 to $55.00 and gave the stock a “buy” rating in a report on Monday, November 11th. Six analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $44.50.

Check Out Our Latest Analysis on G

Genpact Price Performance

G opened at $49.37 on Wednesday. The firm has a 50-day moving average price of $44.80 and a 200-day moving average price of $41.04. The company has a market capitalization of $8.71 billion, a price-to-earnings ratio of 13.56, a PEG ratio of 1.61 and a beta of 1.20. Genpact Limited has a twelve month low of $30.23 and a twelve month high of $49.47. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.50.

Genpact (NYSE:GGet Free Report) last issued its quarterly earnings data on Thursday, November 7th. The business services provider reported $0.75 EPS for the quarter, beating the consensus estimate of $0.71 by $0.04. The company had revenue of $1.21 billion during the quarter, compared to analysts’ expectations of $1.19 billion. Genpact had a net margin of 14.22% and a return on equity of 21.85%. During the same quarter in the previous year, the company earned $0.67 earnings per share. Equities analysts expect that Genpact Limited will post 2.94 EPS for the current year.

Genpact Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

See Also

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:GFree Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.